Pakistani Pharmaceuticals & Biotech Top Dividend Payers

GlaxoSmithKline Pakistan

Market Cap: PK₨106.8b

A biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan.

Highnoon Laboratories

Market Cap: PK₨50.3b

Together with its subsidiary, engages in the development, production, marketing, and distribution of pharmaceutical and allied consumer products in Pakistan, Afghanistan, the United Arab Emirates, Sri Lanka, France, Sudan, Cambodia, Kenya, Iraq, Dubai, Tanzania, and internationally.

Hoechst Pakistan

Market Cap: PK₨38.6b

Together with its subsidiary, manufactures, sells, and trades in pharmaceutical and related products in Pakistan, Afghanistan, and internationally.

Abbott Laboratories (Pakistan)

Market Cap: PK₨85.3b

Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.